Posts by VIVA! Communications
Prescription required for codeine-containing painkillers from 2018
Consumers from early 2018 will no longer be able to purchase codeine-based painkillers, but will rather, require a prescription from their GP or healthcare provider. This follows ongoing concerns about the overuse and abuse of commonly known OTC (over the counter) Schedule 2/3 medicine painkillers to schedule 4 prescription medicines. After years of consideration and…
Read MoreWedding fever & Christmas cheer to cap off a fab 2016 – December 20, 2016
Team VIVA! knows how to party in style, with December being no exception. With Christmas just around the corner and our Account Manager, Mark Henderson, getting hitched on the weekend, there’s been a lot to be merry about this month. Last Tuesday, VIVA! celebrated its end of year Christmas party at Whitewater Restaurant in Manly,…
Read MoreAutism linked to vitamin D deficiency in pregnant women
Pregnant women with low vitamin D levels at 20 weeks are more likely to give birth to a child with autistic traits according to a new study. It has prompted new calls by health professionals to urge the widespread use of vitamin D supplements. Findings by researchers led by Professor John McGrath from the University…
Read MoreSyphilis is back… with a vengeance
When you go to the doctor because you just aren’t feeling that comfortable down there, or you just want a check-up and hear the words ‘you’ve got syphilis’, it’s likely you reach panic mode very quickly. After hitting panic, your next thought is likely, ‘how do I fix it?’ Luckily, azithromycin (penicillin) was invented about…
Read MoreAustralia’s first ‘for-benefit’ pharmaceutical company donating $20,000 to breast cancer medical research
=For Benefit Medicines (FBM), the nation’s first ‘for-benefit’ pharmaceutical company, will donate $20,000 to the Breast Cancer Institute of Australia (BCIA) in Newcastle today (December 9, 2016) FBM’s sole purpose is to distribute 100 per cent of profits to local patient support and medical research organisations. The organisation’s first generic medications – Anastrozole FBM and…
Read More